Bacterial vaccines for fish - An update of the current situation worldwide

被引:0
|
作者
Hastein, T [1 ]
Gudding, R [1 ]
Evensen, O [1 ]
机构
[1] Natl Vet Inst, NO-0033 Oslo, Norway
来源
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
During the last few years, the use of vaccines for disease prevention in aquaculture has expanded both with regard to the number of fish species and number of microbial diseases. According to the responses to a questionnaire received from 41 countries, vaccination is used in the commercial aquaculture of species like Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), sea bass (Dicentrarchus labrax), sea bream (Sparus aurata), barramundi (Lates calcarifer), tilapia (Tilapia spp), turbot (Scophthalmus maximus L.), yellowtail (Seriola quinqueradiata), purplish and gold-striped amberjack (Seriola dumereli), striped jack (Pseudocaranx dentex) and channel catfish (Ictalurus punctatus). The range of bacterial infections for which vaccines are commercially available now comprises classical vibriosis (Listonella anguillarum, Vibrio ordalii), furunculosis (Aeromonas salmonicida subsp. salmonicida), cold-water vibriosis (Vibrio salmonicida), yersiniosis (Yersinia, ruckeri), pasteurellosis (Photobacterium damselae supsp. piscicida), edwardsiellosis (Edwardsiella ictaluri), winter ulcer (Moritella viscosa), and streptococcosis/lactococcosis (Streptococcus iniae, Lactococcus garviae). Furthermore, experimental vaccines are used against diseases such as infection with Vibrio harveyi and Photobacterium damsela subsp. damsela in barramundi, piscirickettsiosis and bacteria(kidney disease in salmonids, as well as infection with Flexibacter maritimus (now: Tenacibaculum maritimum) in turbot. There was good agreement between the information received from different sources in the same country. Most vaccines are licensed products, but some non-licensed vaccines are also used in commercial fish farms. Most bacterial vaccines are inactivated products and recombinant vaccine technology has so far been used to a very limited extent. Salmonid fish are usually immunised with multivalent vaccines by intraperitoneal injection. in marine fish species vaccination is generally performed by immersion, but use of injection vaccination is increasing, particularly in the Mediterranean region. Only limited use of orally administered fish vaccines is reported. In general, the effect of vaccination against bacterial infections is good. The best protection is obtained with injectable, adjuvanted vaccines. However, injection-site adverse reactions often occur when such products are used.
引用
收藏
页码:55 / 74
页数:20
相关论文
共 50 条
  • [41] Contagious bovine pleuropneumonia vaccines: The current situation and the need for improvement
    Tulasne, JJ
    Litamoi, JK
    Morein, B
    Dedieu, L
    Palya, VJ
    Yami, M
    Abusugra, I
    Sylla, D
    Bensaid, A
    REVUE SCIENTIFIQUE ET TECHNIQUE-OFFICE INTERNATIONAL DES EPIZOOTIES, 1996, 15 (04): : 1373 - 1396
  • [42] West Nile virus vaccines - current situation and future directions
    Ulbert, Sebastian
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2337 - 2342
  • [43] Terror attacks worldwide and in Europe-history, overview, current situation
    Wirtz, S.
    Harding, U.
    NOTFALL & RETTUNGSMEDIZIN, 2018, 21 (07): : 553 - 559
  • [44] Vaccines and worldwide utilisation
    Peltola, H
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2000, : 30 - 31
  • [45] WORLDWIDE LEPROSY SITUATION
    不详
    WHO CHRONICLE, 1973, 27 (04) : 171 - 172
  • [46] Current use and management of commercial fish vaccines in Korea
    Hwang, Jee Youn
    Kwon, Mun Gyeong
    Seo, Jung Soo
    Hwang, Seong Don
    Jeong, Ji Min
    Lee, Ji Hoon
    Jeong, Ah Reum
    Jee, Bo Young
    FISH & SHELLFISH IMMUNOLOGY, 2020, 102 : 20 - 27
  • [47] Worldwide situation of dengue
    Rodhain, F
    BULLETIN DE LA SOCIETE DE PATHOLOGIE EXOTIQUE, 1996, 89 (02): : 87 - 90
  • [48] Advances in vaccines developed for bacterial fish diseases, performance and limits
    Ben Hamed, Said
    Teresa Tapia-Paniagua, Silvana
    Angel Morinigo, Miguel
    Tavares Ranzani-Paiva, Maria Jose
    AQUACULTURE RESEARCH, 2021, 52 (06) : 2377 - 2390
  • [49] Small intestinal bacterial overgrowth: current update
    Zafar, Hammad
    Jimenez, Brenda
    Schneider, Alison
    CURRENT OPINION IN GASTROENTEROLOGY, 2023, 39 (06) : 522 - 528
  • [50] Current challenges and improvements in assessing the immunogenicity of bacterial vaccines
    Fantoni, Giulia
    Boccadifuoco, Giuseppe
    Verdirosa, Federica
    Molesti, Eleonora
    Manenti, Alessandro
    Montomoli, Emanuele
    FRONTIERS IN MICROBIOLOGY, 2024, 15